- Hepatitis B
- Hepatitis C
- Hepatitis D
- Hepatitis A
- Hepatitis E
Hepatitis Virus Testing Market was valued at USD 4,163.8 million in 2023 and is poised to grow at a CAGR of 5.9 % over 2024-2030. The hepatitis virus testing market is a rapidly growing segment of the global diagnostics industry focused on the detection and diagnosis of hepatitis virus infections. Hepatitis is a category of viral diseases that predominantly affect the liver and can cause a wide range of liver damage, from moderate inflammation to severe cirrhosis and even liver failure. Hepatitis viruses are categorized as Hepatitis A, B, C, D, and E. Each type of hepatitis virus has different transmission routes and clinical characteristics, making accurate and timely testing crucial for appropriate patient management and treatment. Hepatitis infections remain a major public health problem across the world, with millions of new cases recorded each year. According to WHO, an estimated 58 million people worldwide have chronic hepatitis C virus infection, with around 1.5 million new infections happening each year.
This high frequency of hepatitis infections is a key factor driving the demand for testing and screening services to detect affected people, ultimately driving the hepatitis virus testing market. Moreover, growing awareness and screening programs coupled with increasing healthcare expenditure contribute to the growth of the hepatitis virus testing market. On top of that, growing demand in emerging markets is creating significant opportunities for the growth of the hepatitis virus testing market. However, the high cost of hepatitis virus testing, especially for advanced molecular diagnostic techniques, can be a significant barrier to access hepatitis virus testing. The Companies operating in the hepatitis virus testing market are expanding their product portfolios by offering comprehensive testing solutions.
Hepatitis Virus Testing Market Key Developments:
- In July 2022, Roche introduced new hepatitis C virus diagnostic test the Elecsys HCV Duo immunoassay.
- In November 2021, Molecular Testing Labs launched innovative hepatitis C test options to determine both positivity and viral load.
Global Hepatitis Virus Testing Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
5.9%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Hepatitis Virus Testing Market Dynamics
The continuous development of advanced diagnostic technologies, such as molecular testing, nucleic acid amplification techniques, and immunoassays, enhances the accuracy, speed, and accessibility of hepatitis virus testing. These innovations drive the hepatitis virus testing market growth as healthcare providers seek efficient and reliable testing methods. Moreover, point-of-care testing (POCT) for the hepatitis virus has gained popularity due to its ability to provide rapid results at the patient's bedside or in community settings. POCT allows for timely diagnosis and immediate initiation of treatment, especially in remote or resource-limited areas, which further contribute to the growth and development of the hepatitis virus testing market.
North-America Got Significant Share
Hepatitis Virus Testing Market Regional Analysis
North America is expected to dominate the Hepatitis Virus Testing Market due to the high prevalence of hepatitis infections, well-established healthcare infrastructure, and increased awareness about early diagnosis and disease prevention. Moreover, countries such as China, India, and Japan in Asia-Pacific region is anticipated to witness substantial growth in the Hepatitis Virus Testing Market, primarily driven by the large population base, high burden of hepatitis infections, increase in number of blood transfusions, growing government initiatives for disease control, and increasing adoption of molecular testing methods, and improving healthcare infrastructure.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The hepatitis virus testing market report provides granular level information about the market size, regional market share, historic market (2019-2023) and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Global Hepatitis Virus Testing Market Segmentation
By Disease Type
By Techniques
- Immunoassays
- Molecular Assays
- Others
By Modality
- Laboratory Based Test
- Point-Of-Care Assays
By End User
- Hospitals and Clinics
- Diagnostic Centers
- Blood Banks
- Others
Frequently Asked Questions
The hepatitis virus testing market was valued at USD 4,163.8 Million in 2022 and is expected to grow at 5.9 % CAGR over the forecast period 2023 – 2029.
The growing demand of emerging markets and point-of-care testing advancements, are some of the factors that create potential opportunities for the growth of the hepatitis virus testing market.
Increasing adoption of molecular testing and shift towards automated testing systems are some of the major trends in the hepatitis virus testing market.
Innovita Biological Technology Co. Ltd., General Biologicals Corporation, Nantong, Diagnos Biotechnology Co. Ltd., Transasia Bio-Medicals Ltd., BioGenex , F. Hoffmann- La Roche AG, Diasorin S.p.A, bioMeriuex SA, MedMira Inc, Beckman Coulter Inc, Qiagen GmbH, Bio-Rad Laboratories Inc., Abnova Corporation, Abbott Laboratories, Hologic Inc.are a few companies operating in hepatitis virus testing market.
| 1. Executive Summary |
| 2. Global Hepatitis Virus Testing Market Introduction |
| 2.1. Global Hepatitis Virus Testing Market - Taxonomy |
| 2.2. Global Hepatitis Virus Testing Market - Definitions |
| 2.2.1. Disease Type |
| 2.2.2. Techniques |
| 2.2.3. Modality |
| 2.2.4. End Users |
| 2.2.5. By Region |
| 3. Global Hepatitis Virus Testing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 3.8. USP |
| 3.9. Macro Trends |
| 3.10. Epidemiology |
| 4. Global Hepatitis Virus Testing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Hepatitis Virus Testing Market By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Hepatitis B |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast,. 2024 - 2030 , (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Hepatitis C |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast,. 2024 - 2030 , (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Hepatitis D |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast,. 2024 - 2030 , (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Hepatitis A |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast,. 2024 - 2030 , (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Hepatitis E |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast,. 2024 - 2030 , (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6. Global Hepatitis Virus Testing Market By Techniques, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Immunoassays |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast,. 2024 - 2030 , (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Molecular Assays |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast,. 2024 - 2030 , (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast,. 2024 - 2030 , (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Hepatitis Virus Testing Market By Modality, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Laboratory-Based Test |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Point-Of-Care Assays |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8. Global Hepatitis Virus Testing Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Hospitals and Clinics |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Diagnostic Centers |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Blood Banks |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.Global Hepatitis Virus Testing Market By By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Middle East and Africa (MEA) |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 , (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Hepatitis Virus Testing Market - Opportunity Analysis Index, By Techniques, Disease Type, Modality, End Users, , , , and By Region, 2024 - 2030 |
| 9. North America Hepatitis Virus Testing Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Disease Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Hepatitis B |
| 9.1.2. Hepatitis C |
| 9.1.3. Hepatitis D |
| 9.1.4. Hepatitis A |
| 9.1.5. Hepatitis E |
| 9.2. Techniques Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1. Immunoassays |
| 9.2.2. Molecular Assays |
| 9.2.3. Others |
| 9.3. Modality Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1. Laboratory-Based Test |
| 9.3.2. Point-Of-Care Assays |
| 9.4. End Users Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1. Hospitals and Clinics |
| 9.4.2. Diagnostic Centers |
| 9.4.3. Blood Banks |
| 9.4.4. Others |
| 9.5. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.5.1. United States of America (USA) |
| 9.5.2. Canada |
| 10. Europe Hepatitis Virus Testing Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Disease Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Hepatitis B |
| 10.1.2. Hepatitis C |
| 10.1.3. Hepatitis D |
| 10.1.4. Hepatitis A |
| 10.1.5. Hepatitis E |
| 10.2. Techniques Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Immunoassays |
| 10.2.2. Molecular Assays |
| 10.2.3. Others |
| 10.3. Modality Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1. Laboratory-Based Test |
| 10.3.2. Point-Of-Care Assays |
| 10.4. End Users Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1. Hospitals and Clinics |
| 10.4.2. Diagnostic Centers |
| 10.4.3. Blood Banks |
| 10.4.4. Others |
| 10.5. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1. Germany |
| 10.5.2. France |
| 10.5.3. Italy |
| 10.5.4. United Kingdom (UK) |
| 10.5.5. Spain |
| 10.5.6. Rest of EU |
| 11. Asia Pacific (APAC) Hepatitis Virus Testing Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Disease Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Hepatitis B |
| 11.1.2. Hepatitis C |
| 11.1.3. Hepatitis D |
| 11.1.4. Hepatitis A |
| 11.1.5. Hepatitis E |
| 11.2. Techniques Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Immunoassays |
| 11.2.2. Molecular Assays |
| 11.2.3. Others |
| 11.3. Modality Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1. Laboratory-Based Test |
| 11.3.2. Point-Of-Care Assays |
| 11.4. End Users Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1. Hospitals and Clinics |
| 11.4.2. Diagnostic Centers |
| 11.4.3. Blood Banks |
| 11.4.4. Others |
| 11.5. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1. China |
| 11.5.2. India |
| 11.5.3. Australia and New Zealand (ANZ) |
| 11.5.4. Japan |
| 11.5.5. Rest of APAC |
| 12. Latin America Hepatitis Virus Testing Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Disease Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Hepatitis B |
| 12.1.2. Hepatitis C |
| 12.1.3. Hepatitis D |
| 12.1.4. Hepatitis A |
| 12.1.5. Hepatitis E |
| 12.2. Techniques Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Immunoassays |
| 12.2.2. Molecular Assays |
| 12.2.3. Others |
| 12.3. Modality Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1. Laboratory-Based Test |
| 12.3.2. Point-Of-Care Assays |
| 12.4. End Users Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1. Hospitals and Clinics |
| 12.4.2. Diagnostic Centers |
| 12.4.3. Blood Banks |
| 12.4.4. Others |
| 12.5. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1. Brazil |
| 12.5.2. Mexico |
| 12.5.3. Rest of LA |
| 13. Middle East and Africa (MEA) Hepatitis Virus Testing Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Disease Type Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Hepatitis B |
| 13.1.2. Hepatitis C |
| 13.1.3. Hepatitis D |
| 13.1.4. Hepatitis A |
| 13.1.5. Hepatitis E |
| 13.2. Techniques Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Immunoassays |
| 13.2.2. Molecular Assays |
| 13.2.3. Others |
| 13.3. Modality Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1. Laboratory-Based Test |
| 13.3.2. Point-Of-Care Assays |
| 13.4. End Users Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1. Hospitals and Clinics |
| 13.4.2. Diagnostic Centers |
| 13.4.3. Blood Banks |
| 13.4.4. Others |
| 13.5. Country Analysis, 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1. GCC Countries |
| 13.5.2. South Africa |
| 13.5.3. Rest of MEA |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 14.2.1. Innovita Biological Technology Co. Ltd. |
| 14.2.2. General Biologicals Corporation |
| 14.2.3. Nantong Diagnos Biotechnology Co. Ltd. |
| 14.2.4. Transasia Bio-Medicals Ltd. |
| 14.2.5. BioGenex |
| 14.2.6. F. Hoffmann- La Roche AG |
| 14.2.7. Diasorin S.p.A |
| 14.2.8. bioMeriuex SA |
| 14.2.9. MedMira Inc |
| 14.2.10. Beckman Coulter Inc |
| 14.2.11. Qiagen GmbH |
| 14.2.12. Bio-Rad Laboratories Inc. |
| 14.2.13. Abnova Corporation |
| 14.2.14. Abbott Laboratories |
| 14.2.15. Hologic Inc. |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
- Innovita Biological Technology Co. Ltd.
- General Biologicals Corporation
- Nantong Diagnos Biotechnology Co. Ltd.
- Transasia Bio-Medicals Ltd.
- BioGenex
- Hoffmann- La Roche AG
- Diasorin S.p.A
- bioMeriuex SA
- MedMira Inc
- Beckman Coulter Inc
- Qiagen GmbH
- Bio-Rad Laboratories Inc.
- Abnova Corporation
- Abbott Laboratories
- Hologic Inc.